STERIS’ (TSE:STE – Free Report) – Equities researchers at Atb Cap Markets boosted their FY2025 earnings estimates for STERIS’ in a report released on Wednesday, March 12th. Atb Cap Markets analyst W. Syed now expects that the company will earn $0.59 per share for the year, up from their prior forecast of $0.43. Atb Cap Markets currently has a “Strong-Buy” rating on the stock. Atb Cap Markets also issued estimates for STERIS’’s Q4 2025 earnings at ($0.11) EPS and Q4 2026 earnings at ($0.09) EPS.
Separately, Cormark raised shares of STERIS’ to a “moderate buy” rating in a research report on Monday, January 6th.
STERIS’ Price Performance
STERIS’ Company Profile
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
See Also
- Five stocks we like better than STERIS’
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Can TikTok Stock Picks Really Make You Rich?
- How to Calculate Inflation Rate
- The “Quality” Rotation: Back to Basics Investing
- The 3 Best Fintech Stocks to Buy Now
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
